Related Experiment Video

Updated: May 7, 2026

Percutaneous Contrast Echocardiography-guided Intramyocardial Injection and Cell Delivery in a Large Preclinical Model
14:24

Percutaneous Contrast Echocardiography-guided Intramyocardial Injection and Cell Delivery in a Large Preclinical Model

Published on: January 21, 2018

11.6K

Myocardial inflammation after elective percutaneous coronary intervention

Ioannis Merinopoulos1, U Bhalraam1, Bahman Kasmai2

  • 1Norwich Medical School, University of East Anglia, UK; Department of Cardiology, Norfolk and Norwich University Hospital, UK.

Hellenic Journal of Cardiology : HJC = Hellenike Kardiologike Epitheorese
|July 3, 2024
PubMed

Insights

This study investigated myocardial inflammation after percutaneous coronary intervention (PCI) using ultrasmall superparamagnetic particles of iron oxide (USPIO)-enhanced cardiovascular magnetic resonance (CMR). While a small increase in inflammation was observed, it was not statistically significant, suggesting potential for future research.

Area of Science:

  • Cardiology
  • Medical Imaging
  • Inflammation Research

Background:

  • Inflammation is central to percutaneous coronary intervention (PCI) sequelae.
  • Myocardial inflammation, beyond the vessel wall, is increasingly recognized.
  • Previous studies primarily focused on vascular inflammation post-angioplasty.

Purpose of the Study:

  • To investigate myocardial inflammation following elective, uncomplicated PCI.
  • To utilize ultrasmall superparamagnetic particles of iron oxide (USPIO)-enhanced cardiovascular magnetic resonance (CMR).
  • To assess changes in blood biomarkers alongside CMR findings.

Main Methods:

  • USPIO-enhanced CMR was performed on stable angina patients two weeks post-PCI.
  • A control group of healthy volunteers was included for comparison.
  • Blood biomarkers were measured at baseline, 4 hours, and two weeks post-PCI.

Main Results:

  • A small, non-statistically significant increase in R2∗ values was observed in the PCI-affected myocardium.
  • No significant difference in R2∗ values was found compared to remote or healthy myocardium.
  • PTX3 and IL-6 levels increased significantly, peaking at 4 hours post-PCI.

Conclusions:

  • USPIO-enhanced CMR was employed for the first time to assess myocardial inflammation post-elective PCI.
  • A minor, non-significant increase in myocardial inflammation was detected.
  • This methodology shows promise for future studies targeting post-PCI inflammation.
Abstract

Keywords:
CMRMyocardial inflammationPCIUSPIO

More Related Videos

Postconditioning with Lactate-enriched Blood for Cardioprotection in ST-segment Elevation Myocardial Infarction05:26

Postconditioning with Lactate-enriched Blood for Cardioprotection in ST-segment Elevation Myocardial Infarction

Published on: May 28, 2019

9.3K
An Intact Pericardium Ischemic Rodent Model07:15

An Intact Pericardium Ischemic Rodent Model

Published on: September 2, 2021

2.4K

Related Concept Videos

Myocarditis I: Introduction01:21

Myocarditis I: Introduction

Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...
645
Myocarditis II: Clinical Features and Diagnostic Tests01:27

Myocarditis II: Clinical Features and Diagnostic Tests

Myocarditis is an inflammation of the heart muscle. The symptoms vary widely, encompassing asymptomatic presentations to severe, acute manifestations.Clinical PresentationAsymptomatic cases: In some instances, myocarditis may be asymptomatic, with the infection resolving without intervention. These cases often go undetected unless discovered incidentally through diagnostic imaging or tests conducted for other reasons.General Early Symptoms: Early symptoms of myocarditis are non-specific and can...
493
Myocarditis III: Medical Management01:14

Myocarditis III: Medical Management

Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
343
Pericarditis I: Introduction01:22

Pericarditis I: Introduction

Pericarditis is defined as the inflammation of the pericardium, the thin, sac-like membrane surrounding the heart. This condition can cause significant chest pain and other symptoms, often necessitating medical intervention. The pericardium has two layers: the inner visceral layer and the outer parietal layer, separated by a small amount of fluid that reduces friction during heartbeats.Types of PericarditisPericarditis can be classified into several types based on the duration and nature of the...
758
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
2.1K
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
522